Sialic acid-binding, Ig-like lectin (
Siglec)-F is highly expressed on mouse eosinophils and plays an important role in regulating levels of eosinophilic
lung inflammation. In this study we investigated the mechanism of constitutive and inducible
Siglec-F
ligand expression by lung airway epithelial cells and inflammatory cells in wild-type (WT) and genetically altered mice (
ST3Gal-III heterozygotes, Fuc-TIV/VII double null, STAT6 null). Flow cytometry demonstrated that
Siglec-F
ligands are constitutively expressed in vitro and in vivo in selected lung cell types (epithelial cells, eosinophils, macrophages, and mast cells, but not CD4, CD8, or B cells) and are induced in response to divergent stimuli, including innate stimuli (TLR
ligands, Alternaria), Th2
cytokines (IL-4, IL-13), and adaptive immune stimuli (OVA
allergen). Furthermore, studies of deficient mice demonstrated the greater importance of the
sialyltransferase ST3Gal-III compared with
fucosyltransferases Fuc-TIV/VII in the synthesis of the constitutive and inducible
Siglec-F
ligands by lung epithelial and nonepithelial cells. In keeping with this, ST3Gal-III heterozygote mice (deficient in expression of
Siglec-F
ligands) also had significantly enhanced OVA-induced eosinophilic airway
inflammation associated with reduced eosinophil apoptosis. Reduced eosinophil apoptosis in the lung of ST3Gal-III-deficient mice is likely mediated by reduced epithelial expression of
Siglec-F
ligands as WT eosinophils (which highly express
Siglec-F) cultured with ST3Gal-III-deficient epithelial cells (which do not express
Siglec-F
ligand) showed reduced eosinophil apoptosis compared with WT eosinophils cultured with WT epithelial cells. Overall, these studies demonstrate that ST3Gal-III plays an important role in
Siglec-F
ligand formation and eosinophil apoptosis with resultant effects on eosinophilic
inflammation in the lung.